Abstract Library

#3009 OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel–Baseline Characteristics

Introduction: Information provided to patients (pts) with neuroendocrine tumors (NETs) about burden and treatment proposed may influence pts’ adherence to treatment, outpatient monitoring and quality of life (QoL), but can also cause anxiety.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Hautefeuille V

Authors: Hautefeuille V, Do Cao C, Coriat R, Dominguez S, Mineur L,

Keywords: Patients’ perception of information, Quality of Life, Lanreotide,

#2981 The Distance from Pathology to Molecular Imaging: SSTR Expression Comparison in 100 Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: Somatostatin receptor (SSTR) overexpression is a unique feature of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), which establish the basis for both diagnosis and therapy. SSTR status can be evaluated by immunohistochemical staining (IHC) and 68Ga-DOTATATE PET/CT.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Yu J

Authors: Yu J, Cao F, Yang Z, Sun Y,

Keywords: GEP-NEN, SSTR, PET/CT, IHC,

#1634 Trends of Incidence and Survivals for Gastric Neuroendocrine Neoplasms: An Analysis of 3523 Patients in the SEER Database

Introduction: The published evidence on gastric neuroendocrine neoplasms (g-NENs) is often based on small series of patients.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Long-Long C

Authors: Long-Long C, Jian-Xian L, Jun L, Chao-Hui Z, Ping L,

Keywords: gastric neuroendocrine neoplasms, seer, prognosis, nomogram,

#1633 The Preoperative Blood Lymphocyte-To-Monocyte Ratio Acts As a Superior Prognostic Factor and Predicts Tumor Metastasis in Gastric Neuroendocrine Neoplasms after Surgery

Introduction: A low lymphocyte-to-monocyte ratio (LMR) has been reported to be a predictor of poor survival in patients with various cancers but has not been examined in patients with gastric neuroendocrine neoplasms (g-NENs).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Long-Long C

Authors: Long-Long C, Jian-Xian L, Jun L, Chao-Hui Z, Ping L,

Keywords: gastric neuroendocrine neoplasms, lymphocyte-to-monocyte ratio, prognosis, tumor recurrence,

#1591 Patient-Reported Preferences in Treatments Approved in Neuroendocrine Tumors: A National Survey from the French Group of Endocrine Tumors

Introduction: Patients with advanced neuroendocrine tumors (NETs) benefit from an increasing number of treatments. The patient’s preference could help physicians to choose among these options

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Thomas W

Authors: Plante A, Baudin E, Do Cao C, Hentic O, Dubreuil O,

Keywords: neuroendocrine tumor, toxicity, PRO,